K-numberK251735
Device nameStabilis SA Cervical Stand-Alone System (Various PNs)
ApplicantAcuity Surgical Devices, LLC
Product codeOVE
Device classClass II
Decision dateJul 30, 2025
DecisionSubstantially Equivalent
Regulation888.3080
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Stabilis SA Cervical Stand-Alone System is an intervertebral body fusion device made of titanium alloy manufactured using laser powder bed fusion (L-PBF) additive manufacturing. It is indicated for cervical spine fusion in skeletally mature patients with degenerative disc disease and up to Grade I spondylolisthesis at one or two contiguous levels (C2-T1), using integrated screw-based fixation without supplemental fixation when proper screw placement is achieved.

Technological characteristics

The device uses titanium alloy (Ti-6Al-4V ELI) cages with layered porous lattice structure on surfaces, offered in multiple sizes and configurations including straight and curved endplates, with optional hydroxyapatite coating. Key differences from the primary predicate include new stand-alone cervical indications, additional implant configurations with integrated screw fixation, curved endplate options, updated instrument designs, and a new additive manufacturing supplier, though materials and basic design remain identical to the predicate.

Test standards cited

ASTM F2077 (Test Methods for Intervertebral Body Fusion Devices), ASTM F2267 (Load Induced Subsidence), ASTM F3001 (Additive Manufacturing Titanium-6 Aluminum-4 Vanadium ELI), ASTM F136 (Wrought Titanium-6 Aluminum-4 Vanadium ELI), and ASTM F86 (Surface Preparation and Marking of Metallic Surgical Implants).

Substantial equivalence argument

The subject device shares identical materials, similar dimensions, and identical or similar technological characteristics to the primary predicate (K230639). Worst-case mechanical testing per ASTM F2077 and F2267 demonstrated performance equivalence across static and dynamic loading conditions, subsidence testing, and material composition assessment. The change in additive manufacturing supplier did not identify any new or increased risks, with tensile testing, microstructure, and chemical composition validation confirming acceptance criteria were met. The device therefore raises no new safety or effectiveness issues compared to the predicate devices.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →